Eurobio Scientific Société anonyme (EPA:ALERS)
France · Delayed Price · Currency is EUR 20.80
+0.80 (4.00%)
Aug 3, 2026, 12:54 PM CET
EPA:ALERS Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 20.32 | 21.77 | 49.3 | 47.49 | 92.92 |
Short-Term Investments | 0.35 | 1.29 | 39.73 | 38.44 | 9.47 |
Cash & Short-Term Investments | 20.66 | 23.07 | 89.03 | 85.94 | 102.39 |
Cash Growth | -10.41% | -74.09% | 3.60% | -16.07% | 56.18% |
Accounts Receivable | 33.02 | 32.09 | 26.94 | 32.78 | 43.86 |
Other Receivables | 6.93 | 6.21 | - | - | - |
Total Trade Receivables | 39.95 | 38.3 | 26.94 | 32.78 | 43.86 |
Inventory | 28.63 | 26.92 | 21.45 | 21.65 | 16.29 |
Other Current Assets | 2.34 | 1.31 | 6.5 | 8.32 | 11.06 |
Total Current Assets | 91.58 | 89.59 | 143.91 | 148.69 | 173.6 |
Net Property, Plant & Equipment | 12.63 | 12.77 | 12.3 | 12.66 | 10.05 |
Other Intangible Assets | 151.49 | 153.52 | 153.13 | 154.98 | 21.76 |
Goodwill | 113.97 | 117.4 | 116.03 | 115.8 | 18.17 |
Long-Term Investments | 1.05 | 1.3 | - | - | - |
Other Long-Term Assets | - | - | 6.99 | 14.4 | 4.46 |
Total Assets | 256.76 | 257.17 | 316.33 | 330.73 | 209.87 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 20.87 | 19.02 | 16.82 | 18.53 | 16.77 |
Accrued Expenses | - | - | 9.63 | 11.6 | 12.85 |
Short-Term Debt | 16.02 | 9.77 | 11.16 | - | 1.1 |
Current Portion of Long-Term Debt | - | - | 13.28 | 13.73 | 3.68 |
Current Portion of Leases | - | - | 1.8 | 1.6 | 1.56 |
Unearned Revenue | - | - | 0.2 | 0.44 | 0.16 |
Other Current Liabilities | 33.4 | 46.62 | - | 11.42 | - |
Total Current Liabilities | 70.29 | 75.4 | 52.88 | 57.32 | 36.11 |
Long-Term Debt | - | - | 82.06 | 94.67 | 7.99 |
Long-Term Leases | - | - | 4.35 | 3.97 | 3.44 |
Other Long-Term Liabilities | 2.54 | 2.91 | 4.06 | 3.57 | 3.56 |
Total Long-Term Liabilities | 2.54 | 2.91 | 90.47 | 98.98 | 14.99 |
Total Liabilities | 70.29 | 75.4 | 143.34 | 156.29 | 51.09 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 3.28 | 3.28 | 3.5 | 3.63 | 3.63 |
Additional Paid-in Capital | 20.19 | 20.19 | 33.57 | 40.05 | 40.05 |
Accumulated Other Comprehensive Income | - | 0.16 | 0.16 | 0.33 | 0.31 |
Retained Earnings | 160.45 | 155.23 | 137.94 | 128.98 | 116.88 |
Shareholders' Equity | 183.92 | 178.7 | 175.01 | 172.65 | 160.55 |
Total Liabilities & Equity | 256.76 | 257.17 | 316.33 | 330.73 | 209.87 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 16.02 | 9.77 | 112.64 | 113.97 | 17.76 |
Net Cash (Debt) | 4.65 | 13.3 | -23.61 | -28.04 | 84.62 |
Net Cash Growth | -65.05% | - | - | - | 136.10% |
Net Cash Per Share | 0.45 | 1.30 | -2.10 | -2.46 | 7.78 |
Book Value | 183.92 | 178.7 | 175.01 | 172.65 | 160.55 |
Book Value Per Share | 17.95 | 17.44 | 15.60 | 15.18 | 14.76 |
Tangible Book Value | -81.54 | -92.23 | -94.15 | -98.13 | 120.62 |
Tangible Book Value Per Share | -7.96 | -9.00 | -8.39 | -8.63 | 11.09 |